ICON Public Limited Company
ICLR
Rank in Stocks
#1647
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Share Price
$167.98
Last synced: 2026-10-19
Market Cap
$12.96B
Change (1 day)
-1.29%
Change (1 year)
-10.86%
Country
IE
Trade ICON Public Limited Company (ICLR)
Category
Healthcare
Revenue for ICON Public Limited Company (ICLR)
Revenue in Jun 2026 TTM: $8.25B
According to ICON Public Limited Company latest financial reports the company's current revenue (TTM) is $8.25B. In 2023 the company made a revenue of $8.12B an increase over the revenue in the year 2022 that was $7.74B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for ICON Public Limited Company from 2001 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $8.25B | -0.35% |
| 2024 | $8.28B | 1.99% |
| 2023 | $8.12B | 4.89% |
| 2022 | $7.74B | 41.24% |
| 2021 | $5.48B | 95.93% |
| 2020 | $2.80B | -0.30% |
| 2019 | $2.81B | 8.09% |
| 2018 | $2.60B | 47.62% |
| 2017 | $1.76B | 5.52% |
| 2016 | $1.67B | 5.81% |
| 2015 | $1.57B | 4.77% |
| 2014 | $1.50B | 12.52% |
| 2013 | $1.34B | 19.83% |
| 2012 | $1.12B | 17.90% |
| 2011 | $945.73M | 5.08% |
| 2010 | $900.04M | 1.40% |
| 2009 | $887.61M | 2.58% |
| 2008 | $865.25M | 37.18% |
| 2007 | $630.72M | 38.44% |
| 2006 | $455.60M | 31.60% |
| 2005 | $346.20M | 16.60% |
| 2004 | $296.92M | 31.54% |
| 2003 | $225.73M | 44.18% |
| 2002 | $156.56M | 34.77% |
| 2001 | $116.16M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $46.34B | 461.46% |
US
|
|
| $25.11B | 204.22% |
US
|
|
| $2.71B | -67.20% |
US
|
|
| - | - |
CN
|
|
| $7.37B | -10.67% |
US
|
